Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients

Vogel, K. , I., LaRoche, K. , J., El-Haddad, J., Chaumont, A., & Foster, A. , M. (2016). Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients. Contraception, 94(2), 137-142. doi:https://doi.org/10.1016/j.contraception.2016.04.008
Metadata
TitleExploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients
AuthorsK. Vogel, K. LaRoche, J. El-Haddad, A. Chaumont, A. Foster
AbstractAlthough Canada decriminalized abortion in 1988, significant disparities in access to services and an uneven geographic distribution of providers persists. Health Canada registered mifepristone, the gold standard of medication abortion, in July 2015. Our study explored Canadian women's knowledge of, interest in, and perspectives on mifepristone prior to registration.
JournalContraception
Date2016
Volume94
Issue2
Start page137
End page142
Notearticle